LAXAF — Laxai Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $1.46m
Annual cashflow statement for Laxai Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.276 | 0.21 | -1.63 | -1.93 | -0.404 |
| Depreciation | |||||
| Non-Cash Items | -0.146 | 0.099 | 0.178 | 0.723 | 0.084 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.102 | -0.996 | 0.605 | -0.139 | -0.03 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.353 | -0.124 | -0.845 | -1.34 | -0.35 |
| Capital Expenditures | -0.936 | -1.02 | -0.001 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.21 | 0.04 | -0.35 | 0.147 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.726 | -0.978 | -0.351 | 0.147 | 0 |
| Financing Cash Flow Items | 0 | -0.059 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.108 | 0.718 | 1.15 | 1.2 | 0.348 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.252 | -0.338 | -0.048 | 0.003 | -0.002 |